与辅助疗法相比,单独治疗时使用赛诺巴酸的药理动力学
Vijay Vashi1, William E Rosenfeld2, Louis Ferrari1
1SK Life Science, Inc., Paramus, NJ, USA.
Epilepsy research
|July 10, 2023
概括
预计单独治疗塞诺巴的药理动力学暴露与焦点患者的辅助治疗相似. 这支持酸盐酸盐.
科学领域:
- 药理动力学 药理动力学
- 的治疗方法 治疗
- 药物新陈代谢 药物新陈代谢
背景情况:
- 塞诺巴被FDA批准作为焦点的辅助疗法.
- 需要进一步的研究来支持单一治疗中使用雪诺巴.
- 药理动力学 (PK) 分析可以预测药物暴露水平.
研究的目的:
- 为了评估预测PK暴露的单一治疗和辅助疗法.
- 支持使用赛诺巴作为治疗焦点的单一疗法.
- 为了比较单独治疗和辅助治疗之间的模拟患者血暴露 (AUC).
主要方法:
- 使用960名患者的数据开发了一个人口药理动力学 (PopPK) 模型.
- 在单一治疗和辅助治疗场景中模拟的赛诺巴马特暴露 (AUC).
- 定义的治疗等价性,如果90% CI的AUC比率在0.8-1.25.25之间.
主要成果:
- 克罗巴萨姆降低了19%的塞诺巴马特清除率;卡巴马西平增加了15%.
- 这些变化不被认为具有临床意义.
- 辅助卡巴马泽的AUC比率为0.87 (0.8160.925);对于辅助克洛巴赞,它是1.24 (1.1471.339).
结论:
- 预计单独治疗赛诺巴会产生与辅助治疗相比较的暴露.
- 卡巴马西平的90%CI处于等效范围内;克洛巴萨姆的部分超过了它们.
- 结果支持使用赛诺巴作为治疗焦点发作的单一疗法.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.7K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.2K
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
206
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
206
Sedatives and Hypnotics Drugs: Miscellaneous Agents
203
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
203
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Drug Concentration Versus Time Correlation
895
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
895
Time Course of Drug Effect
2.1K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.1K
Drug Therapy
73
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
73
